 |
NICE
short clinical guideline increases treatment options for patients
with type 2 diabetes |
| |
The new short clinical guideline is a partial
update of last year’s clinical guideline “Type 2 Diabetes (Update)” and examines several new and existing treatments for the management of blood
glucose levels in individuals with type 2 diabete (NICE) |
| |
|
|
NICE
endorses new drugs for type 2 diabetes |
| |
GPs should consider a new drug class, the gliptins,
as a second-line option for treating patients with type 2 diabetes,
NICE has recommended (PULSE) |
| |
|
|
GP
incentive system delivers disappointing results on diabetes |
| |
The GP incentive scheme has not had the dramatic
impact on diabetes care that was predicted when it was introduced
five years ago, researchers have found (Health Service Journal) |
| |
|
|
Special
issue of Diabetes Voice focuses on women and diabetes |
| |
Diabetes Voice, the quarterly magazine of
the International Diabetes Federation, has published a special
issue focusing on women and diabetes (IDF) |
| |
|
|
IDF
CEO discusses global impact of NCDs |
| |
International Diabetes Federation CEO/Executive
Director Ann Keeling appeared on May 19 on Voice of America TV – In Focus, where she was interviewed about the impact of non-communicable diseases
(NCDs) on the world (IDF) |
| |
|
|
IBM,
UNC join to harness medical data |
| |
UNC Health Care has teamed up with IBM to improve
the treatment of patients with diabetes and other diseases by analyzing
a giant database of medical information (News & Observer) |
| |
|
|
CombinatoRx's
diabetes drug meets trial goal, shares up |
| |
CombinatoRx Inc said its anti-diabetic treatment
met its primary goal in a mid-stage trial, sending the biopharmaceutical
company's shares up 39 percent in pre-market trade (Reuters) |
| |
|
|
Diabetes
Drug Shows Promise Against Multiple Sclerosis |
| |
A drug currently FDA-approved for use in diabetes
shows some protective effects in the brains of patients with relapsing
remitting multiple sclerosis (Newswise) |
| |
|
